Skip to main content

Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma.

Tolles J, Bai Y, Baquero M, Harris LN, Rimm DL, Molinaro AM

Publication: Breast Cancer Res (2011) • Vol 13 • Page R51PMID: 21592345View on PubMed

Purpose

The purpose of this paper was to determine the effects of the number of images analyzed using the Automated Quantitative Analysis (AQUA) method on the quantification of immunofluorescence for several cancer biomarkers.

Conclusion

The optimum number of 20x field images required to estimate the expression of a biomarker in a whole tissue section, as assessed by AQUA score, varied based on biomarker and ranged from 3 to 14.

Studies (1)

Purpose

The purpose of this study was to determine the effects of the number of 20x field images analyzed using AQUA on the quantification of immunofluorescence for cancer biomarkers including estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), serine/threonine protein kinase (AKT), extracellular-signal-regulated kinase (ERK), ribosomal protein S6 kinase beta-1 (S6K1), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), cytokeratin, and microtubule-associated protein (MAP)-Tau. Due to the small sample size and number of fields of view, a mathematical simulation was performed for all biomarkers except MAP-Tau, for which direct sampling of 122 whole section slides and the simulation were performed. Only ER-positive breast cancer cases were included.

Summary of Findings

The optimum number of 20x field images required to estimate the expression of a biomarker in a whole tissue section, as assessed by AQUA score, varied based on biomarker and ranged from 3 (cytokeratin) to 14 (MAP-Tau, simulated and direct sampling). In general, a higher number of 20x fields of view were required for markers showing more heterogeneity.
  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
    MorphologyFluorescent microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsAliquot size/volume
    1-35 20x fields of view
    Immunohistochemistry SpecificTargeted peptide/protein
    AKT
    Cytokeratin
    ER
    ERK
    GAPDH
    HER2
    MAP-Tau
    S6K1